Nonstimulant Psychotropic Medication

Desired Effects and Cognitive/Behavioral Adverse Effects
  • Manuel L. Cepeda
Part of the Critical Issues in Neuropsychology book series (CINP)


Most behavioral adverse effects of medications do not differ in quality from similar behaviors that may be present when a child is free of medication. Cognitive adverse effects that are demonstrated with specialized testing may not be apparent in the classroom or when testing with routine educational batteries. Some impairments demonstrated in the laboratory cannot be corroborated during real-life activities, such as operating a motor vehicle. The literature may report adverse events that occur following the administration of a single dose of medication to a healthy volunteer during a drug trial study. The same adverse event may not occur during long-term administration of the same drug to a patient. The medical literature does not always clarify whether problems are life-threatening major medical events, transient effects that will dissipate rather quickly, or “nuisance” effects limited to subjective somatic complaints that are of no demonstrable consequence.


Bipolar Disorder Selective Serotonin Reuptake Inhibitor Antipsychotic Drug Antipsychotic Medication Stimulant Medication 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Aminoff, M. J., Marshall, J., Smith, E., & Wyke, M. (1974). Cognitive function in patients on lithium therapy. British Journal of Psychiatry, 125, 109–112.PubMedCrossRefGoogle Scholar
  2. Anderson, L. T., Campbell, M., Grega, D. M., Perry, R., Small, A. M., & Green, W. H. (1984). Haloperidol in the treatment of infantile autism: Effects upon learning and behavioral symptoms. American Journal of Psychiatry, 141, 1195–1202.PubMedGoogle Scholar
  3. Behrle, F. C., Elkin, M. T., & Laybourne, P. C. (1956). Evaluation of a conditioning device in the treatment of nocturnal enuresis. Pediatrics, 17, 849–856.PubMedGoogle Scholar
  4. Biederman, J., Baldessarini, R. J., Goldblatt, A., Lapey, K. A., Doyle, A., & Hesslein, P. (1993). A naturalistic study of 24-hour electrocardiographic recordings and echocardio-graphic findings in children and adolescents treated with desipramine. Journal of the American Academy of Child and Adolescent Psychiatry, 32, 805–813.Google Scholar
  5. Block, R. I., DeVoe, M., Stanley, B., Stanley, M., & Pomara, N. (1985). Memory performance in individuals with primary degenerative dementia: Its similarity to diazepam-induced impairments. Experimental Aging Research, 11, 151–155.PubMedGoogle Scholar
  6. Bonne, H. L., Etevenon, P., Benyacoub, J., & Slowen, P. (1981). Intellectual efficiency in manic-depressive patients treated with lithium. Acta Psychiatrica Scandinavica, 64, 423–430.CrossRefGoogle Scholar
  7. Braff, D. L., & Saccuzzo, D. P. (1982). Effect of antipsychotic medication on speed of information processing in schizophrenic patients. American Journal of Psychiatry, 139, 1127–1130.PubMedGoogle Scholar
  8. Brumback, R. A., & Staton, R. D. (1980). Neuropsychological study of children during and after remission and endogenous depressive episodes. Perceptual and Motor Skills, 50, 1163–1167.PubMedCrossRefGoogle Scholar
  9. Campbell, M., Small, A. M., Green, W. H., Jennings, M. A., Perry, R., Bennett, W. G., Pedron-Gayol, M., & Anderson, L. (1982). Lithium and haloperidol in hospitalized aggressive children. Psychopharmacology Bulletin, 18, 126–130.Google Scholar
  10. Christodoulous, G. N., Kokkevi, A., Lykouras, E. P., Stefanis, C. N., & Papadimitriou, G. N. (1981). Effects of lithium on memory. American Journal of Psychiatry, 18, 847–848.Google Scholar
  11. Cleghorn, J. M., Kaplan, R. D., Szechtman, B., Szechtman, H., & Brown, G. M. (1990). Neuroleptic drug effects on cognitive function in schizophrenia. Schizophrenia Research, 3, 211–219.PubMedCrossRefGoogle Scholar
  12. Cole, S. O. (1986). Effects of benzodiazepines on acquisition and performance: A critical assessment. Neuroscience and Biobehavioral Reviews, 10, 265–272.PubMedCrossRefGoogle Scholar
  13. deGier, J. J., Hart, B. J., Nelemans, F. A., & Bergman, H. (1981). Psychomotor performance and real driving performance of outpatients receiving diazepam. Psychopharmacology, 73, 340–344.CrossRefGoogle Scholar
  14. Department of Health and Human Services, United States Government. (1982). Use of approved drugs for unlabeled indications. FDA Drug Bulletin, 12, 4–5.Google Scholar
  15. Dietch, J. T., and Jennings, R. K. (1988). Aggressive dyscontrol in patients treated with benzodiazepines. Journal of Clinical Psychiatry, 49, 184–188.PubMedGoogle Scholar
  16. DiMascio, A., Giller, D. R., and Shader, R. I. (1968). Behavioral toxicity of psychotropic drugs: III. Effects on perceptual and cognitive functions. Connecticut Medicine, 32, 771–775.PubMedGoogle Scholar
  17. DiMascio, A., Heninger, G., and Klerman, G. L. (1964). Psychopharmacology of imipramine and desipramine: A comparative study of their effects in normal males. Psychopharmacologia, 5, 361–371.PubMedCrossRefGoogle Scholar
  18. Dugas, J. E. (1977). Mood elevation and medication. Diseases of the Nervous System, 38, 958.PubMedGoogle Scholar
  19. Eitan, N., Levin, Y., Ben-Artzi, E., Levy, A., and Neumann, M. (1992). Effects of antipsychotic drugs on memory functions of schizophrenic patients. Acta Psychiatrica Scandinavica, 85, 74–76.PubMedCrossRefGoogle Scholar
  20. Fayen, M., Goldman, M. B., Moulthrop, M. A., and Luchins, D. J. (1988). Differential memory function with dopaminergic versus anticholinergic treatment of drug-induced extrapyramidal symptoms. American Journal of Psychiatry, 145, 483–486.PubMedGoogle Scholar
  21. Ferguson, H. B., and Simeon, J. G. (1984). Evaluating drug effects on children’s cognitive functioning. Progress in Neuropsychopharmacology and Biological Psychiatry, 8, 683–686.CrossRefGoogle Scholar
  22. Gardos, G. (1980). Disinhibition of behavior by antianxiety drugs. Psychosomatics, 21, 1025–1026.PubMedGoogle Scholar
  23. Ghoneim, M. M., and Mewaldt, S. P. (1990). Benzodiazepines and human memory: A review. Anesthesiology, 72, 926–938.PubMedCrossRefGoogle Scholar
  24. Gittelman-Klein, R., and Klein, D. F. (1971). Controlled imipramine treatment of school phobia. Archives of General Psychiatry, 25, 204–207.CrossRefGoogle Scholar
  25. Gittelman-Klein, R., and Klein, D. F. (1973). School phobia: Diagnostic considerations in the light of imipramine effect. Journal of Nervous and Mental Disease, 156, 199–215.Google Scholar
  26. Glass, R. M., Uhlenhuth, E. H., Harrel, F. W., Matuzas, W., and Fischman, M. W. (1981). Cognitive dysfunction and imipramine in outpatient depressives. Archives of General Psychiatry, 38, 1048–1051.PubMedCrossRefGoogle Scholar
  27. Glass, R. M., Uhlenhuth, E. H., and Weinreb, H. (1978). Imipramine-reversible cognitive deficit in outpatient depressives. Psychopharmacology Bulletin, 14, 10–11.PubMedGoogle Scholar
  28. Golombok, S., Moodley, P., and Ladner, M. (1988). Cognitive impairment in long term benzodiazepine users. Psychological Medicine, 18, 365–374.PubMedCrossRefGoogle Scholar
  29. Gotestam, K. G., andAnderson, B. E. (1978). Subjective effects and vigilance after diazepam and oxazepam in normal subjects. Acta Psychiatrica Scandinavica, 274 (Suppl.), 117–128.PubMedCrossRefGoogle Scholar
  30. Greenberg, H. R., and Carrillo, C. (1968). Thioridazine-induced inhibition of masturbatory ejaculation in an adolescent. American Journal of Psychiatry, 124, 151–153.Google Scholar
  31. Guatrieri, C. T., and Patterson, D. R. (1986). Neuroleptic-induced tics in two hyperactive children. American Journal of Psychiatry, 143, 1176–1177.Google Scholar
  32. Healey, M., Pickens, R., Meisch, R., and McKenna, T. (1983). Effects of clorazepate, diazepam, lorazepam and placebo on human memory. Journal of Clinical Psychiatry, 44, 436–439.PubMedGoogle Scholar
  33. Helper, M. M., Wilcott, R. C., and Garfield, S. L. (1963). Effects of chlorpromazine on learning and related processes in emotionally disturbed children. Journal of Consulting Psychology, 27, 1–9.Google Scholar
  34. Henry, G. M., Weingartner, H., and Murphy, D. L. (1973). Influence of affective states and psychoactive drugs on verbal learning and memory. American Journal of Psychiatry, 130, 966–971.PubMedGoogle Scholar
  35. Hobi, V., Gastpar, M., Gastpar, G., Gilsdorf, U., Kielholz, P., and Schwarz, E. (1982). Driving ability of depressive patients under antidepressants. Journal of International Medical Research, 10, 65–81.PubMedGoogle Scholar
  36. Huey, L. Y., Janowsky, D. S., Judd, L. L., Abrams, A., Parker, D., and Clopton, P. (1981). Effects of lithium carbonate on methylphenidate-induced mood, behavior and cognitive process. Psychopharmacology, 73, 161–164.PubMedCrossRefGoogle Scholar
  37. Israel, M., and Beaudry, P. (1988). Carbamazepine in psychiatry: A review. Canadian Journal of Psychiatry, 33, 577–584.Google Scholar
  38. Jani, N. N., and Wise, T. N. (1988). Antidepressants and inhibited female orgasm: A literature review. Journal of Sex and Marital Therapy, 14, 279–284.PubMedCrossRefGoogle Scholar
  39. Judd, L. L., Hubbard, B., Janowsky, D. S., Huey, L. Y., and Takahashi, K. I. (1977). The effect of lithium carbonate on the cognitive functions of normal subjects. Archives of General Psychiatry, 34, 355–357.PubMedCrossRefGoogle Scholar
  40. Kardash, S., Hillman, E. S., and Werry, J. (1968). Efficacy of imipramine in childhood enuresis: A double-blind control study with placebo. Journal of the Canadian Medical Association, 99, 263–266.Google Scholar
  41. Keeler, M. H., Prange, A. J., and Reifler, C. B. (1966). Effects of imipramine and thioridazine on set and action. Diseases of the Nervous System, 27, 798–802.Google Scholar
  42. King, D. J. (1990). The effect of neuroleptics on cognitive and psychomotor function. British Journal of Psychiatry, 157, 799–811.PubMedCrossRefGoogle Scholar
  43. Koelega, H. S. (1989). Benzodiazepine and vigilance perfor- mance: A review. Psychopharmacology, 98, 145–156.PubMedCrossRefGoogle Scholar
  44. Kornetsky, C., Williams, J. E. G., and Bird, M. (1990). Attentional and motivational effects of psychoactive drugs. NIDA Research Monograph, 97, 177–192.PubMedGoogle Scholar
  45. Kupietz, S. S., and Balka, E. B. (1976). Alterations in the vigilance performance of children receiving amitriptyline and methylphenidate pharmacotherapy. Psychopharmacology, 50, 29–33.PubMedCrossRefGoogle Scholar
  46. Kusumo, K. S., and Vaughn, M. (1977). Effects of lithium salts on memory. British Journal of Psychiatry, 131, 453–457.PubMedCrossRefGoogle Scholar
  47. Lamping, D. L., Spring, B., and Gelenberg, A. J. (1984). Effects of two antidepressants on memory performance in depressed outpatients: A double blind study. Psychopharmacology, 84, 254–261.PubMedCrossRefGoogle Scholar
  48. Legg, J. F., and Stiff, M. P. (1976). Drug-related test patterns of de- pressed patients. Psychopharmacology, 50, 205–210.PubMedCrossRefGoogle Scholar
  49. Lister, R. G. (1985). The amnestic actions of benzodiazepines in man. Neuroscience and Biobehavioral Reviews, 9, 87–94.PubMedCrossRefGoogle Scholar
  50. Livingston, R. L., Zucker, D. K., Isenberg, K., and Wetzel, R. D. (1983). Tricyclic antidepressants and delirium. Journal of Clinical Psychiatry, 44, 173–176.Google Scholar
  51. Lucki, I., Rickels, K., Giesecke, M. A., and Geller, A. (1987). Differential effects of the anxiolytic drugs, diazepam and buspirone, on memory function. British Journal of Clinical Pharmacology, 23, 207–211.PubMedCrossRefGoogle Scholar
  52. Marusarz, T. Z., Wolpert, E. A., and Koh, S. D. (1981). Memory processing with lithium carbonate. Journal of Clinical Psychiatry, 42, 190–192.PubMedGoogle Scholar
  53. Meador-Woodruff, J. H., Akil, M., Wisner-Carlson, R., and Grunhaus, L. (1988). Behavioral, and cognitive toxicity related to elevated plasma tricyclic antidepressant levels. Journal of Clinical Psychopharmacology, 8, 28–32.PubMedCrossRefGoogle Scholar
  54. Medical Economics. (1995). Physicians’ desk reference. Montvale, NJ: Author.Google Scholar
  55. Miller, N. S., and Gold, M. S. (1990). Benzodiazepine tolerance, dependence, abuse and addiction. Journal of Psychoactive Drugs, 22, 23–33.PubMedCrossRefGoogle Scholar
  56. Murphy, D. L. (1977). The behavioral toxicity of monoamine oxidase-inhibiting antidepressants. Advances in Pharmacology and Chemotherapy, 14, 71–105.PubMedCrossRefGoogle Scholar
  57. Petrie, W. M. (1980). Sexual effects of antidepressants and psychomotor stimulant drugs. Modern Problems of Pharmacopsychiatry, 15, 77–90.PubMedGoogle Scholar
  58. Pishkin, V., Fishkin, S. M., Shurley, J. T., Lawrence, B. E., and Lovallo, W. R. (1978). Cognitive and psychophysiologie response to doxepin and chlordiazepoxide. Comprehensive Psychiatry, 19, 171–178.PubMedCrossRefGoogle Scholar
  59. Platt, J. E., Campbell, M., Green, W. H., and Grega, D. M. (1984). Cognitive effects of lithium carbonate and haloperidol in treatment-resistant aggressive children. Archives of General Psychiatry, 41, 657–662.PubMedCrossRefGoogle Scholar
  60. Pleak, R. R., Birmaher, B., Gavrilescu, A., Abichandani, C., and Williams, D. T. (1988). Mania and neuropsychiatrie excitation following carbamazepine. Journal of the American Academy of Child and Adolescent Psychiatry, 27, 500–503.PubMedCrossRefGoogle Scholar
  61. Quinn, P. O., and Rapoport, J. L. (1975). One year follow-up of hyperactive boys treated with imipramine or methylphenidate. American Journal of Psychiatry, 132, 241–245.PubMedGoogle Scholar
  62. Rapoport, J. (1965). Childhood behavior and learning problems treated with imipramine. International Journal of Psychiatry, 1, 635–642.Google Scholar
  63. Rapoport, J. L., Quinn, P. O., Bradbard, G., Riddle, K. D., and Brooks, E. (1974). Imipramine and methylphenidate treatments of hyperactive boys. Archives of General Psychiatry, 30, 789–793.Google Scholar
  64. Riddle, M. A., Nelson, J. C., Kleinman, C. S., Rasmusson, A., Leckman, J. F., King, R. A., and Cohen, D. J. (1991). Sudden death in children receiving norpramin: A review of three reported cases and commentary. Journal of the American Academy of Child and Adolescent Psychiatry, 30, 845–846.CrossRefGoogle Scholar
  65. Rosenbaum, J. F., and Pollack, M. H. (1988). Anhedonic ejaculation with desipramine. International Journal of Psychiatry in Medicine, 18, 85–88.PubMedCrossRefGoogle Scholar
  66. Ross, R. J., Smallberg, S., and Weingartner, H. (1984). The effects of desmethylimipramine on cognitive function in healthy subjects. Psychiatry Research, 12, 89–97.PubMedCrossRefGoogle Scholar
  67. Segraves, R. T. (1988). Psychiatric drugs and inhibited female orgasm. Journal of Sex and Marital Therapy, 14, 202–207.PubMedCrossRefGoogle Scholar
  68. Shay, J., Sanchez, L. E., Cueva, J. E., Armenteros, J. L., Overall, J. E., and Campbell, M. (1993). Neuroleptic-related dyskinesias and stereotypies in autistic children: Videotaped ratings. Psychopharmacology Bulletin, 29, 359–363.PubMedGoogle Scholar
  69. Shen, W. W., and Lindbergh, S. S. (1990). Inhibited female orgasm resulting from psychotropic drugs: A five year updated clinical review. Journal of Reproductive Medicine, 37, 11–14.Google Scholar
  70. Silva, R. R., Malone, R. P., Anderson, L. T., Shay, J., and Campbell, M. (1993). Haloperidol withdrawal and weight changes in autistic children. Psychopharmacology Bulletin, 29, 287–291.PubMedGoogle Scholar
  71. Sliwa, J. A., and Lis, S. (1993). Drug-induced dysphagia. Archives of Physical Medicine and Rehabilitation, 74, 445–447.PubMedGoogle Scholar
  72. Spiegel, D. E., and Keith-Spiegel, P. (1967). The effects of carphenazine, trifluoperazine and chlorpromazine on ward behavior, physiological functioning and psychological test scores in chronic schizophrenic patients. The Journal of Nervous and Mental Disease, 144, 111–116.PubMedCrossRefGoogle Scholar
  73. Sprague, R. L., Barnes, K. R., and Werry, J. S. (1970). Methylphenidate and thioridazine: Learning, reaction time, activity and classroom behavior in disturbed children. American Journal of Orthopsychiatry, 40, 615–628.PubMedCrossRefGoogle Scholar
  74. Squire, L. R., Judd, L. L., Janowsky, D. S., and Huey, L. Y. (1980). Effects of lithium carbonate on memory and other cognitive functions.AmericanJournalofPsychiatry, 137, 1042–1046.Google Scholar
  75. Staton, R. D., Wilson, H., and Brumback, R. A. (1981). Cognitive improvement associated with tricyclic antidepressant treatment of childhood major depressive illness. Perceptual and Motor Skills, 53, 219–234.PubMedCrossRefGoogle Scholar
  76. Stenberg, A., and Lackgren, G. (1994). Desmopressin tablets in the treatment of severe nocturnal enuresis in adolescents. Pediatrics, 94, 841–846.Google Scholar
  77. Sternberg, D. E., and Jarvik, M. E. (1976). Memory functions in depression. Archives of General Psychiatry, 33, 219–224.Google Scholar
  78. Strauss, W. H., and Kleiser, E. (1990). Cognitive disturbances in neuroleptic therapy. Acta Psychiatrica Scandinavica, 82 (Suppl. 358), 56–57.CrossRefGoogle Scholar
  79. Strauss, W. H., Kleiser, E., and Leuthcke, H. (1988). Dyscognitive syndromes in neuroleptic therapy. Pharmacopsychiatry, 21, 298–299.PubMedCrossRefGoogle Scholar
  80. Sweeney, J. A., Keilp, J. G., Haas, G. L., Hill, J., and Weiden, P. J. (1991). Relationships between medication treatments and neuropsychological test performance in schizophrenia. Psychiatry Research, 37, 297–308.PubMedCrossRefGoogle Scholar
  81. Thienhaus, O. J., Allen, A., Bennett, J. A., Chopra, Y. M., & Zemlan, F. P. (1990). Anticholinergic serum levels and cognitive performance. European Archives of Psychiatry and Clinical Neuroscience, 240, 28–33.PubMedCrossRefGoogle Scholar
  82. Thompson, P. J. (1991). Antidepressants and memory: A review. Human Psychopharmacology, 6, 79–90.CrossRefGoogle Scholar
  83. Thompson, P. J., & Trimble, M. R. (1982). Non-MAOI antidepressant drugs and cognitive functions: A review. Psychological Medicine, 12, 539–548.PubMedCrossRefGoogle Scholar
  84. Tingelstad, J. B. (1991). The cardiotoxicity of the tricyclics. Journal of the American Academy of Child and Adolescent Psychiatry, 30, 845–846.PubMedGoogle Scholar
  85. Weise, C. C., O’Reilly, R. P., & Hesbacher, P. (1972). Perphenazine-amitriptyline in neurotic underachieving students: A controlled study. Diseases of the Nervous System, 33, 318–325.PubMedGoogle Scholar
  86. Weiss, A. A., Robinson, S., & Dasberg, H. (1973). Changes in mental functioning accompanying antipsychotic drug therapy. Annals of Psychiatry and Related Disciplines, 11, 134–140.PubMedGoogle Scholar
  87. Werry, J. S., Aman, M. G., & Diamond, E. (1979). Imipramine and methylphenidate in hyperactive children. Journal of Child Psychology and Psychiatry, 21, 27–35.Google Scholar
  88. Werry, J. S., Dowrick, R. W., Lampen, E. L., & Vamos, M. J. (1975). Imipramine in enuresis-Psychological and physiological effect. Journal of Child Psychology and Psychiatry, 16, 289–299.PubMedCrossRefGoogle Scholar
  89. Werry, J. S., Weiss, G., Douglas, V., & Martin, M. A. (1966). Studies on the hyperactive child: The effect of chlorpromazine upon behavior and learning ability. Journal of the American Academy of Child Psychiatry, 5, 292–312.PubMedCrossRefGoogle Scholar
  90. Wilens, T. E., Biederman, J., Spencer, T., & Geist, D. E. (1993). A retrospective study of serum level and electrocardio-graphic effects of nortriptyline in children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 32, 270–277.PubMedCrossRefGoogle Scholar
  91. Wittenborn, J. R. (1988). Assessment of the effect of drugs on memory. Psychopharmacology Series, 6, 67–78.PubMedGoogle Scholar
  92. Zimmermann-Tansella, C. (1984). Psychological performance of normal subjects on tasks commonly used in evaluation of anxiolytic drugs. Perceptual and Motor Skills, 58, 803–810.PubMedCrossRefGoogle Scholar
  93. Zisook, S., & DeVaul, R. (1977). Adverse behavioral effects of benzodiazepines. The Journal of Family Practice, 5, 963–966.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1997

Authors and Affiliations

  • Manuel L. Cepeda
    • 1
  1. 1.Department of Psychiatry, College of MedicineUniversity of South AlabamaMobileUSA

Personalised recommendations